Instil Bio, Inc. , a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL).
Instil Bio stock last closed at $10.92, down 4.17% from the previous day, and has decreased 58.3% in one year. It has underperformed other stocks in the Biotechnology industry by 0.11 percentage points. Instil Bio stock is currently +2.06% from its 52-week low of $10.70, and -74.48% from its 52-week high of $42.79.
As of Dec 5, 2025, there are 6.78M shares of TIL outstanding. The market cap of TIL is $74.06M. In the past 24 hours, 50,600 TIL shares were traded.
You will need a brokerage account to access the NASDAQ market and buy TIL stock.
Based on our research, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you'll need to fill out some personal information so you are able to buy TIL today.
Now that you've finished signing up on one of the best stock apps, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your investment account.
Once you have identified the best place to buy Instil Bio stock, it's very important to evaluate their stock prior to buying, so you truly wrap your head around the risk and opportunity.
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on TIL's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge TIL's true value.
Using relative valuations measures:
You can do more valuation research on TIL's stock here.
Out of 1 sell side analysts who track TIL, the consensus analyst rating on TIL is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Instil Bio stock forecast page.
Over the past 12 months, executives and large shareholders at TIL have bought as many shares as they have sold.
Sandeep Laumas, CFO and CBO of TIL, was the latest TIL insider to buy. They bought $197,200.00 worth of TIL shares on Sep 10, 2025.
Learn more about who owns TIL shares here.
No, Instil Bio doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two primary options:
Click the Open button and eToro will execute the order.
If you need more help with buying stocks on eToro, watch the how to video below:
Now that you own some shares in TIL, you'll want to stay up-to-date on your stock purchase.
Create a watchlist to get notified of important updates regarding your TIL stock.
To reiterate, here are the 6 steps for buying Instil Bio stock:
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to watch your investment in Instil Bio, click the button below.